Regulatory information
This section contains information provided for under article 221-1 of the Règlement général de l’AMF.
Investors
Financial and regulatory information
HALF-YEARLY FINANCIAL REPORTS/QUARTERLY FINANCIAL INFORMATION
Nicox is committed to presenting itself to the financial and investor community in the most transparent way.
Nicox Provides Third Quarter 2021 Business and Financial Highlights
October 19, 2021Half yearly management report June 30, 2021 (in French)
French September 27, 2021Nicox First Half 2021 Financial Results and Business Update
English September 27, 2021Nicox Provides Second Quarter 2021 Business and Financial Highlights and Strategic Update
16 July 2021Nicox Provides First Quarter 2021 Business Update and Financial Highlights
April 19, 2021Nicox Announces 2020 Financial Results and 2021 Key Milestones
English March 1, 2021Financial calendar
31 December
| 2020 Year-end results | March 1, 2020 |
| 2021 First quarter | April 19, 2021 |
| 2021 Second quarter | July 16, 2021 |
| 2021 Half-year results | September 27, 2021 |
| 2021 Third quarter | October 19, 2021 |
| 2021 Fourth quarter | January 2022 |
| Year End: 31 December |
Corporate Presentation
Webcasts
|
October 21, 2021 OIS Glaucoma Innovation Showcase: Nicox’s presentation | |
|
June 1, 2021 Ophthalmology Innovation Summit podcast: Interview with Michele Garufi |
Voting rights
This section contains information provided for under article 221-1 of the Règlement général de l’AMF.
Older documents
Share liquidity agreements
This section contains information provided for under article 221-1 of the Règlement général de l’AMF.
| Half-year liquidity contract statement with Kepler Cheuvreux (as of June 30, 2021) |
| Half-year liquidity contract statement with Kepler Cheuvreux |
| Liquidity contract with Kepler Cheuvreux |